| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911457A1 Composition to treat or prevent gastrointestinal infection |
| 04/16/2008 | EP1911451A1 Protein-kinase CK2 inhibitors and their therapeutic applications |
| 04/16/2008 | EP1911450A1 Use of cymipristones for treating aids |
| 04/16/2008 | EP1911448A2 Lipoxins and Aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 04/16/2008 | EP1910837A2 Methods and compositions for diagnosis and treatment of influenza |
| 04/16/2008 | EP1910409A2 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 04/16/2008 | EP1910408A2 Bifunctional protein anchors |
| 04/16/2008 | EP1910404A1 Hcv ns3 protease inhibitors |
| 04/16/2008 | EP1910378A1 Hepatitis c inhibitor peptide analogs |
| 04/16/2008 | EP1910375A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 04/16/2008 | EP1910360A2 Hiv reverse transcriptase inhibitors |
| 04/16/2008 | EP1910282A1 Pleuromutilin derivatives useful as antibacterials |
| 04/16/2008 | EP1909841A2 Vaginal treatment composition |
| 04/16/2008 | EP1909802A2 Steroidal glycoside compounds as core 2 glcnac-t inhibitors |
| 04/16/2008 | EP1909786A2 TRICYCLIC 6-ALKYLIDENE-PENEM ß-LACTAMASE INHIBITORS AND ß-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC |
| 04/16/2008 | EP1909762A2 Amorphous efavirenz and the production thereof |
| 04/16/2008 | EP1711492B1 Substituted quinolines and their use as mycobacterial inhibitors |
| 04/16/2008 | EP1467771B1 Mycobacterial vaccine |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1222289B1 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/16/2008 | EP1189912B1 Novel crystalline forms of a macrolide antibiotic |
| 04/16/2008 | EP1109574B1 Vaccine against sexually transmitted diseases |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | EP1026945B1 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions |
| 04/16/2008 | EP0931093B1 Helicobacter pylori live vaccine |
| 04/16/2008 | CN101163788A Skin treatment compositions |
| 04/16/2008 | CN101163703A Imidazo [1, 2-a]pyridine derivatives useful as peptide deformylase (pdf) inhibitors |
| 04/16/2008 | CN101163697A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
| 04/16/2008 | CN101163695A Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
| 04/16/2008 | CN101163683A 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 04/16/2008 | CN101163674A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
| 04/16/2008 | CN101163499A Surface-located streptococcus pneumoniae polypeptides |
| 04/16/2008 | CN101163493A Uronic acid and probiotics |
| 04/16/2008 | CN101163486A Use of azithromycin for the production of a medicament for treatment of ocular infections |
| 04/16/2008 | CN101163415A Nutritional supplement for HIV patients |
| 04/16/2008 | CN101161668A Application of flavone c-glycosides in preparation of drugs curing and preventing hepatitis |
| 04/16/2008 | CN101161652A Quinolizine derivatives having antibacterial activity |
| 04/16/2008 | CN101161286A Varicella attenuation live vaccine |
| 04/16/2008 | CN101161285A Influenza virus cracking vaccine |
| 04/16/2008 | CN101161284A Novel antimicrobial peptides with heparin binding activity |
| 04/16/2008 | CN101161260A A medicine for treating beriberi |
| 04/16/2008 | CN101161252A A pellet type isatis root effervescent and its preparing method |
| 04/16/2008 | CN101161248A Novel anti-hepatitis B virus medicine and its preparing method |
| 04/16/2008 | CN101161232A Method of producing intravenous injection human hepatitis b immune globulin |
| 04/16/2008 | CN100381464C Multiple variants of meningococcal protein NMB1870 |
| 04/16/2008 | CN100381463C Immunogen for producing vaccine or medicine to treat hepatitis B, its preparation process and use |
| 04/16/2008 | CN100381456C A segment differential nucleotide sequence of smallpox virus genom |
| 04/16/2008 | CN100381455C The novel antisense-oligos with better stability and antisense effect |
| 04/16/2008 | CN100381445C Preparing process of cefetamet sodium |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381436C Flavonoid compound and process for producing the same |
| 04/16/2008 | CN100381434C Manufacturing method of traditional Chinese medicine formulation containing emblic leafflower fruit extract possessing anticancer, antibiotic actions |
| 04/16/2008 | CN100381426C Growth promotion method |
| 04/16/2008 | CN100381171C Composite hepatitis B virus surface antigen granule containing S1, S2 and S proantigen determinants |
| 04/16/2008 | CN100381170C Foot and mouth disease bivalent polypeptide vaccine and its preparation method and use |
| 04/16/2008 | CN100381151C Dermatosis treating Chinese medicine prepn |
| 04/16/2008 | CN100381128C Inclusion compound of ants supercritical extracts and preparation process thereof |
| 04/16/2008 | CN100381120C Fibrauretine powder for injection and its production process |
| 04/16/2008 | CN100381116C Quisnon dispersion tablet |
| 04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
| 04/15/2008 | US7358367 Present invention relates to the new 3-decladinosyl derivatives of 9-deoxo-9a-aza9a-homoerythromycin a 9a, 11-cyclic carbamates |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358259 Tetrazoloquinoline, triazoloquinoline, and oxazoloquinoline compounds, e.g., 9-chloro-N-isopropoxytetrazolo[1,5-a]quinoline-4-carboxamide |
| 04/15/2008 | US7358252 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever |
| 04/15/2008 | US7358249 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/15/2008 | US7358093 Aztreonam L-lysine and methods for the preparation and analysis thereof |
| 04/15/2008 | US7358068 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses; non-sequence complementary mode of action; drug screening |
| 04/15/2008 | US7357936 immunostimulant (3-de-O-acylated monophosphoryl lipid A) adsorbed onto metallic salt (aluminium hydroxide or aluminium phosphate); second salt with antigen which elicits immune response to polypeptide or pathogen; Hepatitis, human papilloma virus |
| 04/15/2008 | US7357930 Methods and formulations for targeting infectious agents bearing host cell proteins |
| 04/15/2008 | US7357925 Method for treating disorders and diseases treatable with human fibroblast interferon |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2263201C Cross-protective equine herpesvirus preparations and method of making and using the same |
| 04/15/2008 | CA2171614C Pharmaceutical composition containing sialic acid derivatives |
| 04/15/2008 | CA2169764C Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 04/15/2008 | CA2114859C Cytotoxic and antiviral compound |
| 04/15/2008 | CA2082155C Swine pneumonia vaccine and method of preparation |
| 04/12/2008 | CA2603199A1 Shigella ipad protein and its use as a vaccine against shigella infection |
| 04/12/2008 | CA2563214A1 Shigella ipad protein and its use as a potential vaccine against shigella infection |
| 04/10/2008 | WO2008042806A2 Stilbenedisulfonic acid derivatives as inhibitors of retroviral integrase |
| 04/10/2008 | WO2008042240A2 Enantiomerically pure phosphoindoles as hiv inhibitors |
| 04/10/2008 | WO2008041882A1 Method for affecting viruses by means of an agent based on 2,8-ditioxo-1h-pyrano[2,3-d;6,5-d'] dipyrimidine and 10-aza-analogs thereof (variants) |
| 04/10/2008 | WO2008041710A1 Precipitated/inactivated influenza vaccine and method for production thereof |
| 04/10/2008 | WO2008041703A1 Adjuvant for influenza vaccine and influenza vaccine |
| 04/10/2008 | WO2008041665A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 04/10/2008 | WO2008041176A2 Process for the preparation of form i and form ii of ritonavir |
| 04/10/2008 | WO2008041087A1 An improved process for preparation of amorphous nelfinavir mesylate |
| 04/10/2008 | WO2008040778A2 Carboxamide 4-[(4-pyridyl)amino] pyrimidines for the treatment of hepatitis c |
| 04/10/2008 | WO2008040757A1 Vaccines against chlamydial infection |
| 04/10/2008 | WO2008040691A1 Therapeutic vaccine comprising mycobacterial heat shock protein 70 |
| 04/10/2008 | WO2008040516A2 Microbiological composition and use thereof |
| 04/10/2008 | WO2008040469A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 04/10/2008 | WO2008040332A1 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 04/10/2008 | WO2008040236A1 Flavones derivatives, preparation methods and uses thereof |
| 04/10/2008 | WO2008040155A1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |